Peter Hanlon

Frailty, polypharmacy, and the case for pragmatic prescribing in primary care Primary care clinicians are often caught between conflicting recommendations for clinical care. On one side, specialist guidelines and trial evidence urge intensive treatment, such as tight blood pres...

🆕 In their Comment, Peter Hanlon and colleagues discuss pragmatic prescribing for people with moderate or severe frailty in primary care
Read the full Comment here ➡️ www.thelancet.com/journals/lan...

13.02.2026 13:36 — 👍 4    🔁 6    💬 0    📌 0

Does age or sex make a difference in how well newer glucose-lowering drugs work in patients with type 2 diabetes?

SGLT2 inhibitors may be more effective in reducing cardiovascular events in older adults with type 2 #diabetes.

➡️ Read more: ja.ma/3Cqvk7z

#MedSky

05.02.2025 15:40 — 👍 12    🔁 4    💬 1    📌 1

Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes This network meta-analysis assesses whether age or sex are associated with differences in the efficacy of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipe...

Our new paper in @jama.com on age and sex differences in efficacy of type 2 diabetes treatments. It shows that older age is associated with greater cardiovascular benefits of SGLT2 inhibitors despite smaller improvement in HbA1c compared to younger people.

jamanetwork.com/journals/jam...

04.02.2025 06:40 — 👍 3    🔁 0    💬 0    📌 0

A male doctor is writing notes in a consultation with a male patient.

GP practices in deprived areas should be prioritised for resource, in order to allow them to provide effective care to some of the most unwell and vulnerable patients in society.

New study by Dr Marianne McCallum, Prof Sara Macdonald and @francesmair.bsky.social

www.gla.ac.uk/news/headlin...

06.01.2025 12:45 — 👍 12    🔁 6    💬 1    📌 2